<500 g | ≥500 g | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Outcome | Belgium | France | Italy | Portugal | UK | All | p Value | Belgium | France | Italy | Portugal | UK | All | p Value | |||
22 weeks gestation | Births | N (all births) | 25 | 61 | 34 | 20 | 56 | 196 | – | 27 | 30 | 16 | 8 | 17 | 98 | – | |
N (live births) | 2 | 6 | 6 | 0 | 11 | 25 | – | 6 | 7 | 5 | 2 | 4 | 24 | – | |||
% live born | 8 | 10 | 18 | 0 | 20 | 13 | 0.135 | 22 | 23 | 31 | 25 | 24 | 25 | 0.973 | |||
Active treatment | Antenatal steroids | % (all births) | 4 | 0 | 3 | 0 | 5 | 2 | 0.489 | 0 | 0 | 25 | 13 | 0 | 5 | 0.002 | |
Respiratory support | % (all births) | 0 | 0 | 9 | 0 | 0 | 2 | 0.006 | 0 | 0 | 25 | 13 | 0 | 5 | 0.001 | ||
Survival to discharge | Any survival | % (all births) | 0 | 0 | 0 | 0 | 0 | 0 | – | 0 | 0 | 0 | 0 | 0 | 0 | – | |
Morbidity free | % (all births) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
23 weeks gestation | Births | N (all births) | 9 | 25 | 25 | 12 | 17 | 88 | – | 24 | 75 | 49 | 18 | 56 | 222 | – | |
N (live births) | 3 | 5 | 4 | 1 | 3 | 16 | – | 8 | 25 | 29 | 6 | 39 | 107 | – | |||
% live born | 33 | 20 | 16 | 8 | 18 | 18 | 0.679 | 33 | 33 | 59 | 33 | 70 | 48 | <0.001 | |||
Active treatment | Antenatal steroids | % (all births) | 11 | 10 | 21 | 8 | 29 | 16 | 0.500 | 4 | 0 | 58 | 33 | 58 | 31 | <0.001 | |
Respiratory support | % (all births) | 0 | 0 | 12 | 0 | 6 | 5 | 0.243 | 4 | 0 | 49 | 22 | 54 | 27 | <0.001 | ||
Survival to discharge | Any survival | % (all births) | 0 | 0 | 4 | 0 | 0 | 1 | 0.636 | 0 | 0 | 14 | 0 | 25 | 9 | <0.001 | |
Morbidity free | % (all births) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 2 | 1 | ||||
24 weeks gestation | Births | N (all births) | 5 | 20 | 7 | 7 | 16 | 55 | – | 55 | 82 | 68 | 42 | 123 | 370 | – | |
N (live births) | 2 | 1 | 5 | 3 | 2 | 13 | – | 41 | 53 | 52 | 32 | 96 | 274 | – | |||
% live born | 40 | 5 | 71 | 43 | 13 | 24 | 0.003 | 75 | 65 | 77 | 76 | 78 | 74 | 0.275 | |||
Active treatment | Antenatal steroids | % (all births) | 40 | 22 | 71 | 57 | 50 | 43 | 0.179 | 60 | 50 | 74 | 81 | 77 | 68 | <0.001 | |
Respiratory support | % (all births) | 40 | 0 | 43 | 29 | 13 | 16 | 0.033 | 56 | 40 | 75 | 71 | 75 | 64 | <0.001 | ||
Survival to discharge | Any survival | % (all births) | 20 | 0 | 0 | 0 | 0 | 2 | 0.037 | 36 | 21 | 32 | 26 | 50 | 36 | <0.001 | |
Morbidity free | % (all births) | 0 | 0 | 0 | 0 | 0 | 0 | 11 | 7 | 13 | 0 | 4 | 7 | ||||
25 weeks gestation | Births | N (all births) | 9 | 8 | 7 | 7 | 12 | 43 | – | 47 | 98 | 60 | 44 | 128 | 377 | – | |
N (live births) | 2 | 2 | 3 | 3 | 3 | 13 | – | 40 | 81 | 50 | 37 | 93 | 301 | – | |||
% live born | 22 | 25 | 43 | 43 | 25 | 30 | 0.810 | 85 | 83 | 83 | 84 | 73 | 80 | 0.175 | |||
Active treatment | Antenatal steroids | % (all births) | 22 | 0 | 57 | 43 | 50 | 34 | 0.138 | 55 | 68 | 76 | 80 | 78 | 72 | 0.027 | |
Respiratory support | % (all births) | 22 | 13 | 43 | 43 | 17 | 26 | 0.483 | 81 | 76 | 82 | 82 | 72 | 77 | 0.470 | ||
Survival to discharge | Any survival | % (all births) | 11 | 0 | 0 | 14 | 8 | 7 | 0.741 | 49 | 52 | 52 | 45 | 55 | 52 | 0.863 | |
Morbidity free | % (all births) | 0 | 0 | 0 | 0 | 0 | 0 | 21 | 28 | 18 | 20 | 7 | 18 |
Please note: regions comprise: Belgium (Flanders); France (Burgundy, Ile-de-France, Northern); Italy (Emilia Romagna, Lazio, Marche); Portugal (Northern region, Lisbon); UK (East Midlands, Northern, Yorkshire).